Loading…
Loading…
AMGEN Inc
NASDAQ · Stock Profile · Market Cap $189.27B
Current Price
$351.48
-2.67%GoodMoat Value
$393.67
12.0% undervaluedTrading 12% below its estimated fair value of $393.67.
Forward estimates use 24.1% FCF growth (CAGR)
Net Debt: 45.5B
8.4B
FY24
8.5B
FY24
33.4B
FY24
8.1B
FY25
9.2B
FY25
9.6B
FY25
36.8B
FY25
746M
FY24
2.8B
FY24
4.1B
FY24
1.7B
FY25
1.4B
FY25
3.2B
FY25
7.7B
FY25
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions. Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
California, USA
Earnings per share grew at a 24.1% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
2.71%
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines. More than 45 years ago, Amgen helped establish the biotechnology industry at its U.S. headquarters in Thousand Oaks, California, and it remains at the cutting edge of innovation, using technology and human genetic data to push beyond what is known today. Amgen is advancing a broad and deep pipeline and portfolio of medicines to treat cancer, inflammatory conditions, rare diseases, heart disease and obesity and obesity-related conditions. Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Country
California, USA